Nomura Asset Management CO LTD Caribou Biosciences, Inc. Transaction History

Nomura Asset Management CO LTD

12 transactions

Quarter	Operation	Price Per share
Q4 2023 Feb 09, 2024	BUY	$3.58 - $6.25 $0 - $0
Q3 2023 Nov 03, 2023	BUY	$4.08 - $8.14 $0 - $0
Q2 2023 Aug 14, 2023	BUY	$4.04 - $5.47 $0 - $0
Q1 2023 May 11, 2023	BUY	$4.3 - $7.78 $0 - $0
Q4 2022 Feb 14, 2023	BUY	$5.57 - $11.01 $0 - $0
Q3 2022 Nov 14, 2022	BUY	$5.34 - $12.79 $0 - $0
Q3 2022 Nov 10, 2022	BUY	$5.34 - $12.79 $0 - $0
Q3 2022 Nov 10, 2022	BUY	$5.34 - $12.79 $0 - $0
Q2 2022 Aug 12, 2022	BUY	$5.1 - $9.74 $0 - $0
Q1 2022 May 13, 2022	BUY	$8.42 - $15.32 $0 - $0
Q4 2021 Feb 01, 2022	BUY	$14.59 - $23.26 $0 - $0
Q3 2021 Nov 12, 2021	BUY	$15.75 - $30.29 $0 - $0

135

52.6M

148K

70.7K

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $123M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.